Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RenovoRx (RNXT) Liabilities and Shareholders Equity (2024 - 2025)

RenovoRx's Liabilities and Shareholders Equity history spans 2 years, with the latest figure at $11.2 million for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 11.71% year-over-year to $11.2 million; the TTM value through Sep 2025 reached $49.0 million, changed N/A, while the annual FY2024 figure was $8.1 million, N/A changed from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $11.2 million at RenovoRx, down from $13.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $16.0 million in Q1 2025 and bottomed at $4.8 million in Q1 2024.